Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Champions Oncology Return on Tangible Equity 2010-2025 | CSBR

Current and historical return on tangible equity values for Champions Oncology (CSBR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Champions Oncology Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-01-31 $0.01B $0.01B 1200.00%
2024-10-31 $0.00B $0.00B 80.00%
2024-07-31 $0.00B $0.00B 320.00%
2024-04-30 $-0.01B $0.00B 1600.00%
2024-01-31 $-0.01B $0.00B -1100.00%
2023-10-31 $-0.01B $0.00B -307.69%
2023-07-31 $-0.01B $0.00B -145.45%
2023-04-30 $-0.01B $0.00B -68.97%
2023-01-31 $0.00B $0.01B -23.53%
2022-10-31 $0.00B $0.01B 11.11%
2022-07-31 $0.00B $0.01B 11.43%
2022-04-30 $0.00B $0.01B 12.12%
2022-01-31 $0.00B $0.01B 0.00%
2021-10-31 $0.00B $0.01B 0.00%
2021-07-31 $0.00B $0.01B 0.00%
2021-04-30 $0.00B $0.01B 0.00%
2021-01-31 $0.00B $0.01B -16.00%
2020-10-31 $0.00B $0.01B -40.00%
2020-07-31 $0.00B $0.01B -57.14%
2020-04-30 $0.00B $0.01B -120.00%
2020-01-31 $0.00B $0.00B -57.14%
2019-10-31 $0.00B $0.00B -66.67%
2019-07-31 $0.00B $0.00B -66.67%
2019-04-30 $0.00B $0.00B 0.00%
2019-01-31 $0.00B $0.00B -200.00%
2018-10-31 $0.00B $0.00B 0.00%
2018-07-31 $0.00B $0.00B 400.00%
2018-04-30 $0.00B $0.00B 800.00%
2018-01-31 $0.00B $0.00B 0.00%
2017-10-31 $0.00B $0.00B -1600.00%
2017-07-31 $-0.01B $0.00B -500.00%
2017-04-30 $-0.01B $0.00B -400.00%
2017-01-31 $-0.01B $0.00B -457.14%
2016-10-31 $-0.01B $0.00B -450.00%
2016-07-31 $-0.01B $0.00B -550.00%
2016-04-30 $-0.01B $0.00B -440.00%
2016-01-31 $-0.01B $0.00B -282.35%
2015-10-31 $-0.01B $0.00B -520.00%
2015-07-31 $-0.01B $0.01B -1300.00%
2015-04-30 $-0.01B $0.01B 5600.00%
2015-01-31 $-0.01B $-0.01B 960.00%
2014-10-31 $-0.01B $0.00B -1000.00%
2014-07-31 $-0.01B $0.00B 600.00%
2014-04-30 $-0.01B $0.00B 155.56%
2014-01-31 $-0.01B $0.00B 90.32%
2013-10-31 $-0.01B $-0.01B 65.12%
2013-07-31 $-0.01B $-0.01B 73.68%
2013-04-30 $-0.01B $-0.01B 72.73%
2013-01-31 $-0.01B $-0.01B 96.55%
2012-10-31 $-0.01B $-0.01B 128.00%
2012-07-31 $-0.01B $-0.01B 160.00%
2012-04-30 $-0.01B $-0.01B 240.00%
2012-01-31 $-0.01B $0.00B 360.00%
2011-10-31 $-0.01B $0.00B 700.00%
2011-07-31 $-0.01B $0.00B 0.00%
2011-04-30 $0.00B $0.00B -533.33%
2011-01-31 $0.00B $0.00B -160.00%
2010-10-31 $0.00B $0.00B -300.00%
2010-07-31 $0.00B $0.00B -533.33%
2010-04-30 $0.00B $0.00B -800.00%
2010-01-31 $0.00B $0.00B -800.00%
2009-10-31 $0.00B $0.00B -533.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.087B $0.050B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.579B 31.73
Zoetis (ZTS) United States $71.389B 26.64
Takeda Pharmaceutical (TAK) Japan $44.547B 8.86
Daiichi Sankyo, - (DSNKY) Japan $44.407B 22.59
Sandoz Group AG (SDZNY) Switzerland $20.218B 0.00
Summit Therapeutics (SMMT) United States $17.148B 0.00
Merck (MKKGY) Germany $16.879B 12.37
United Therapeutics (UTHR) United States $13.709B 12.13
Shionogi (SGIOY) Japan $12.740B 12.76
Neurocrine Biosciences (NBIX) United States $11.903B 40.77
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.779B 63.24
Stevanato Group S.p.A (STVN) Italy $7.062B 43.19
Madrigal Pharmaceuticals (MDGL) United States $6.479B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.397B 0.00
Ionis Pharmaceuticals (IONS) United States $5.251B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.922B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.901B 10.16
Hypermarcas (HYPMY) Brazil $2.869B 18.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.136B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.054B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.682B 0.00
Guardian Pharmacy Services (GRDN) United States $1.577B 0.00
Indivior (INDV) United States $1.526B 6.47
Evotec AG (EVO) Germany $1.399B 0.00
Dyne Therapeutics (DYN) United States $1.334B 0.00
ARS Pharmaceuticals (SPRY) United States $1.198B 0.00
Ocular Therapeutix (OCUL) United States $1.142B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Collegium Pharmaceutical (COLL) United States $0.943B 5.08
Harrow (HROW) United States $0.940B 0.00
Enliven Therapeutics (ELVN) United States $0.874B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.860B 0.00
Ardelyx (ARDX) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
Xeris Biopharma Holdings (XERS) United States $0.749B 0.00
AleAnna (ANNA) United States $0.700B 0.00
Akebia Therapeutics (AKBA) United States $0.667B 0.00
Xencor (XNCR) United States $0.584B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Savara (SVRA) United States $0.538B 0.00
Bioventus (BVS) United States $0.537B 13.62
CytoDyn (CYDY) United States $0.505B 0.00
Elite Pharmaceuticals (ELTP) United States $0.482B 0.00
Relay Therapeutics (RLAY) United States $0.478B 0.00
Altimmune (ALT) United States $0.469B 0.00
Zevra Therapeutics (ZVRA) United States $0.461B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.457B 0.00
Siga Technologies (SIGA) United States $0.423B 8.84
Amylyx Pharmaceuticals (AMLX) United States $0.403B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Oruka Therapeutics (ORKA) United States $0.354B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.353B 9.54
Heron Therapeutics (HRTX) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.90
ProKidney (PROK) United States $0.249B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.173B 0.00
Liminatus Pharma (LIMN) $0.172B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.168B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Esperion Therapeutics (ESPR) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
4D Molecular Therapeutics (FDMT) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Korro Bio (KRRO) United States $0.136B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
OptiNose (OPTN) United States $0.096B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Surrozen (SRZN) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Karyopharm Therapeutics (KPTI) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
BioLineRx (BLRX) Israel $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00